Radiology

Autonomix Medical, Inc. Announces Abstract Highlighting Technology and Early Proof-of-Concept Study Results Accepted at the Society of Interventional Radiology (SIR) Annual Scientific Meeting

THE WOODLANDS, TX, March 06, 2025 (GLOBE NEWSWIRE) — Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated, today announced its abstract has been accepted for poster presentation at the 2025 Society of Interventional Radiology (“SIR”) Annual Scientific Meeting being held March 29-April 2, 2025 in in Nashville, Tennessee.

Positron Corporation Secures Agreement for Three NeuSight PET-CT 64 Slice Scanners

Niagara Falls, NY, Feb. 27, 2025 (GLOBE NEWSWIRE) — Positron Corporation (OTC: POSC), a leading molecular imaging medical device company specializing in PET and PET-CT imaging systems and clinical support services, is pleased to announce it has entered an agreement for three NeuSight PET-CT 64-slice scanners under its Prime Rental Program, to a leading cardiovascular diagnostic, management, and treatment practice.  

Konica Minolta Healthcare and ImagineSoftware Announce Groundbreaking Strategic Agreement to Expand Offerings, Driving Innovation Through Technology Integration

WAYNE, N.J. and CHARLOTTE, N.C., Feb. 27, 2025 (GLOBE NEWSWIRE) — Konica Minolta Healthcare Americas, Inc. (“Konica Minolta”) and ImagineSoftware (“Imagine”) today announced an integration agreement joining Imagine’s innovative, artificial intelligence-driven platform for automated radiology billing, ImagineOne®, with Konica Minolta’s Exa® PACS|RIS solution. The agreement marks an exciting milestone in the evolution of autonomous technology and a continued commitment to push the boundaries of what’s possible in radiology.

RenovoRx Advances Commercialization of RenovoCath® with Several New Purchase Orders, Including Customer Reorders

Initial Revenues Expected this Quarter, and Customer Pipeline for RenovoCath Standalone Device Continues to Expand, Including High Volume National Cancer Institute-Designated Centers RenovoCath Gaining Validation in an Initial U.S. Market Estimated at $400 Million Annually MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a life sciences company […]

Bracco and Zereau Join Forces for Innovative Research Program Aimed at Improving Sustainability in Medical Imaging

26th FEBRUARY 2025, Milan – Bracco Imaging SpA, a world leader in diagnostic imaging and Zereau BV, a provider of unique water technology for the healthcare sector, announced today they have signed an agreement to launch the second stage of a groundbreaking research program aimed at improving the sustainability of […]

DeepHealth Introduces New AI-Powered Radiology Informatics and Population Screening Solutions at #ECR2025

VIENNA, Feb. 26, 2025 (GLOBE NEWSWIRE) — DeepHealth, Inc., a global leader in AI-powered health informatics and a wholly-owned subsidiary of RadNet, Inc. (Nasdaq: RDNT), will introduce next-generation AI-powered radiology informatics and population screening solutions at the European Congress of Radiology (ECR) 2025 in Vienna. With the aim of empowering breakthroughs in care enabled by imaging, DeepHealth’s suite of solutions addresses critical clinical and operational challenges experienced by healthcare providers around the world. DeepHealth’s solutions are powered by DeepHealth OS, a secure, scalable, and cloud-native operating system that integrates data across various solutions and enables interoperability with broader healthcare IT ecosystems. Moreover, to enable AI adoption at scale, DeepHealth has established strategic collaborations enabling integrated solutions with ecosystem industry leaders.